QUESTRAN
NDC 49884-936, Cholestyramine, powder, for suspension, from Par Health USA, LLC.
- Product NDC
- 49884-936
- Status
- Listed
- Labeler
- Par Health USA, LLC
- Dosage form
- POWDER, FOR SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA077204
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/49884-936 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CHOLESTYRAMINE4 g/9g
Pharmacologic classes
Bile Acid Sequestrant [EPC]; Bile-acid Binding Activity [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 49884-936-65 | 49884093665 | 60 PACKET in 1 CARTON (49884-936-65) / 9 g in 1 PACKET (49884-936-64) |
| 49884-936-66 | 49884093666 | 378 g in 1 CAN (49884-936-66) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/362ddd91-a63f-4ec6-841a-75785dd208c8
Use it
Look up 49884-936 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/49884-936 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 49884-936. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.